Caroline Gordon

Active 1984–2025

191
Papers
40,689
Citations
100
h-index
184
i10-index

Citations

Citations per year for Caroline Gordon1984: 2 citations1990: 2 citations1991: 9 citations1992: 3 citations1993: 2 citations1994: 18 citations1995: 12 citations1996: 21 citations1997: 24 citations1998: 29 citations1999: 38 citations2000: 47 citations2001: 50 citations2002: 58 citations2003: 57 citations2004: 70 citations2005: 77 citations2006: 101 citations2007: 123 citations2008: 138 citations2009: 231 citations2010: 229 citations2011: 261 citations2012: 233 citations2013: 265 citations2014: 263 citations2015: 290 citations2016: 346 citations2017: 372 citations2018: 297 citations2019: 1,275 citations2020: 1,365 citations2021: 1,332 citations2022: 1,111 citations2023: 703 citations2024: 1,352 citations2025: 574 citations2026: 10 citations1985–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,446 citing papers, 19.8% of this breakdownUnited Kingdom: 1,172 citing papers, 9.5% of this breakdownChina: 882 citing papers, 7.1% of this breakdownItaly: 689 citing papers, 5.6% of this breakdownCanada: 567 citing papers, 4.6% of this breakdownGermany: 535 citing papers, 4.3% of this breakdownFrance: 447 citing papers, 3.6% of this breakdownSpain: 439 citing papers, 3.5% of this breakdownSweden: 416 citing papers, 3.4% of this breakdownNetherlands: 362 citing papers, 2.9% of this breakdownJapan: 311 citing papers, 2.5% of this breakdownAustralia: 293 citing papers, 2.4% of this breakdown
0%19.8%Other 30.8%

Fields

  • Medicine84%
  • Immunology and Microbiology8.2%
  • Biochemistry, Genetics and Molecular Biology5%
  • Neuroscience0.8%
  • Health Professions0.4%
  • Dentistry0.4%
  • Other1.2%

Topics

  • Systemic Lupus Erythematosus Research20.8%
  • Rheumatoid Arthritis Research and Therapies7%
  • T-cell and B-cell Immunology4.4%
  • Systemic Sclerosis and Related Diseases3.4%
  • Monoclonal and Polyclonal Antibodies Research3.2%
  • Atherosclerosis and Cardiovascular Diseases2.4%
  • Other58.8%

Coauthors

All papers

Open in search
  1. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder - Arthritis & Rheumatism 2012 cited by 5,295

  2. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 2,017

  3. Systemic lupus erythematosus

    Authors: , , , , , , , - Nature Reviews Disease Primers 2016 cited by 1,355

  4. Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

    Authors: , , , , , , , , , , , - Arthritis & Rheumatism 2009 cited by 1,392

  5. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 cited by 349

  6. The frequency and outcome of lupus nephritis: results from an international inception cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asad Zoma, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, S. Sam Lim, Thomas Stoll, Murat İnanç, Kenneth Kalunian, Diane L. Kamen, Peter J. Maddison, Christine Peschken, Søren Jacobsen, Anca Askanase, Chris Theriault, Kara Thompson, Vernon T. Farewell - Lara D. Veeken 2015 cited by 632

  7. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Davidson, Sarah Fordham, Claire Jones, Christopher Joyce, Anoop Kuttikat, Zoe McLaren, Karen Merrison, Devesh Mewar, Amanda Mootoo, Emma Williams - Lara D. Veeken 2022 cited by 210

  8. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jozef Rovenský, Josef S Smolen, Carlos Vasconcelos, Alexandre E. Voskuyl, Anne Voss, Elena Zakharova, Asad Zoma, Matthias Schneider - Annals of the Rheumatic Diseases 2014 cited by 727

  9. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta‐Analysis of the Centers for Disease Control and Prevention National Lupus Registries

    Authors: , , , , , , , , , , - Arthritis & Rheumatology 2021 cited by 283

  10. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , - Lara D. Veeken 2005 cited by 635

  11. Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2021 cited by 151

  12. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 cited by 357

  13. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meggan Mackay, Manuel Ramos‐Casals, Ronald van Vollenhoven, Kenneth Kalunian, Guillermo Ruiz‐Irastorza, Sam Lim, Diane L. Kamen, Christine Peschken, Murat İnanç, Murray B. Urowitz - Annals of the Rheumatic Diseases 2014 cited by 566

  14. openalex_id:w4226427866

    Authors: , , , , , , , , , cited by 90

  15. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

    Authors: , , , , , , , , , , , , , , , - Lara D. Veeken 2017 cited by 357

  16. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guillermo Ruiz‐Irastorza, Sam Lim, Murat İnanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Jill P. Buyon, David Sontag, Karen H. Costenbader - Annals of the Rheumatic Diseases 2023 cited by 81

  17. Mortality in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Y. St. Pierre, Ann E. Clarke, Rosalind Ramsey‐Goldman - Arthritis & Rheumatism 2006 cited by 1,187

  18. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials

    Authors: , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2016 cited by 236

  19. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

    Authors: , , , , , , - Arthritis & Rheumatism 1997 cited by 614

  20. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 727

  21. Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Z Amoura, P Carle, E Hachulla, C Jorgensen, J Sibilia, J Viallard, J Braun, F Hiepe, A Kuhn, H Lorenz, R Schmidt, H Schulze-Koops, J Wacker, L Settas, S Mouli Veeravalli, A Balbir-Gurman, P Langevitz, D Mevorach, Y Molad, S Bae, CS Cho, HY Kim, C Suh, D Andersone, N Ziade, A Baranauskaite, S Stropuviene, S Gun, N Kong, W Sulaiman, C Ramos Remus, C Saldate Alonso, T Huizinga, P Tak, P van Paassen, C Arroyo, H Gomez, E Perez, E Ramiterre, E Salido, M Brzosko, D Chudzik, A Dyczek, S Jeka, S Sierakowski, Z Zdrojewski, O Barbarash, O Ershova, A Gordienko, N Lomareva, Y Shvarts, V Sorotskaya, N Vezikova, S Yakushin, M Bogic, A Dimic, N Damjanov, R Petrovic, L Stojanovic, A Kalla, I Louw, S Nayiager, H Reuter, C Spargo, D Whitelaw, J Carbonell Abello, A Fernandez Nebro, J Gomez Reino, F Lopez Longo, J von Kempis and 31 more - Annals of the Rheumatic Diseases 2014 cited by 309

  22. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Ramos‐Casals, Kristján Steinsson, Asad Zoma, Anca Askanase, Munther A. Khamashta, Ian N Bruce, Murat İnanç, Michał Abrahamowicz, Sasha Bernatsky - Annals of the Rheumatic Diseases 2021 cited by 98

  23. Population‐Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

    Authors: , , , , , , , , , , , , - Arthritis & Rheumatology 2013 cited by 443

  24. The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program

    Authors: , , , , , , , , , , , , , , - Arthritis & Rheumatology 2017 cited by 185